Search

everythinglearnresearchcommunity

for

Search:↓

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Koilonychia in alopecia areata can improve with oral corticosteroids.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.